MGX
Metagenomi, Inc.
1.20$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 9,982.3% | 172.8% | -204.2% | -208.6% | -352.6% | |
| 159.3% | 10.1% | 9.4% | 10.3% | 21.1% | |
| 154.3% | 11.4% | 15.5% | 31.0% | 47.0% | |
| 19,035.0% | 404.0% | -59.1% | -114.1% | -87.6% | |
| 1,194.7% | 81.3% | 21.9% | 6.0% | 2.3% | |
| -30,582.7% | -710.5% | 102.2% | -168.6% | 410.7% | |
| 12,335.0% | 0.0% | – | – | – | |
| 16,428.8% | 1,393.0% | 2.3% | 160.7% | -1.4% | |
| -4,171.6% | 855.3% | -99.8% | -216.5% | 56.6% | |
| 8,787.7% | 91.6% | -226.2% | -214.5% | -354.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.